Source content
FAA Guide for Aviation Medical Examiners · Version 10/28/2026 · page 867
Guide Official Revision Description Reason for Update
Version Date Number Of Change
Heart Disease ( ) listing to
improve search function.
2020 12/30/2020 2. Administrative In Pharmaceuticals, Do Not
Issue/ Do Not Fly, added
note and hyperlinks:
“For airmen seeking more
information, see Medications
and Flying and What Over
The Counter Medications
Can I Take and Still Be Safe
to Fly?”
2020 11/25/2020 1. Medical Policy In Diabetes Mellitus - Type II,
Medication Controlled (Not
Insulin), in Acceptable
combination of Diabetes
Medication Chart, revised
observation times when
initiating new diabetes
therapy using monotherapy
or new combination
medications.
2020 11/25/2020 2. Administrative In General Information,
added link to Aerospace
Medical Disposition Tables.
2020 10/28/2020 1. Medical Policy In Disease Protocols,
Coronary Heart Disease and
Thromboembolic Disease
were revised to group blood
clotting disorders.
2020 09/30/2020 1. Medical Policy In Diabetes Mellitus Type I or
Type II Insulin Treated -
CGM Option, revised
required glucose parameters
time–in-range to 80-180
mg/dL.
2020 09/30/2020 2. Medical Policy In Diabetes Mellitus Type I or
Type II Insulin Treated -
CGM Option, revised Airman
Information sheet.
2020 09/30/2020 3. Medical Policy In Diabetes Mellitus Type I or
Type II Insulin Treated -
CGM Option, revised Initial
Certificate Consideration
Requirements, (Changes
made to Item #1 Initial
Comprehensive Report, Item
Shown as extracted from the FAA PDF, without paraphrasing. Tables and forms may lose their layout. Underlined references open the Guide location they name.
